ACQUISITION OF SANGAMO THERAPEUTICS FRANCE S.A.S. - (Tables)

3 Months Ended

Mar. 31, 2020

Business Combinations [Abstract]

Summary of Estimated Fair Value of Net Assets Acquired

The following table summarizes the estimated consideration transferred and the fair value of the net assets acquired as of the Acquisition Date (in thousands):

	October 1, 2018
Consideration transferred	$	45,911
Fair value of non-controlling interest	35,829
Fair value of Sangamo France	$	81,740
Cash	$	4,779
Current assets	2,427
Property and equipment	1,857
IPR&D	55,019
Other assets	155
Current liabilities	(9,761)
Assumed debt liabilities	(4,933)
Deferred tax liability, net	(6,798)
Fair value of net identifiable assets acquired	42,745
Goodwill	38,995
Total fair value of net assets acquired	$	81,740

Summary of Non-controlling Interest

Non-controlling interest as of March 31, 2020 was as follows (in thousands):

	Total
Balance at December 31, 2019	$	185
Loss attributable to non-controlling interest	(61)
Balance at March 31, 2020	$	124